Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

A patient with Rothmund-Thomson syndrome showed skin changes, hair loss, and dental defects but no cataracts or skeletal issues.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

More research is needed to confirm the long-term effects of oral drugs for chronic central serous chorioretinopathy.

Taking riboflavin and eating less lysine can help some people with a specific genetic disorder avoid brain damage.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

A substance from Caulerpa racemosa seaweed may protect against skin damage caused by air pollution by reducing oxidative stress and cell death.

Indinavir and ritonavir therapy can cause reversible hair loss.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

The patient improved after antiviral treatment for a viral infection.

Cronkhite-Canada syndrome can sometimes show unusual colonic adenomatous polyps.

Alitretinoin may help treat alopecia areata.

Most skin rashes in rheumatoid arthritis patients were not caused by their medication, and careful evaluation allowed most to keep taking their beneficial treatment.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

A medicine company has recalled a drug because it contained an unlisted blood pressure medication.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

A sick foal with Rhodococcus equi pneumonia was successfully treated for multiple complications with targeted therapy and careful monitoring.